JWA
AKRO

JFS Wealth Advisors’s Akero Therapeutics AKRO Stock Holding History

JFS Wealth Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$48 – 1918
2025
Q3 		$48 Buy
+1
New +$48 ﹤0.01% 1870

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JFS Wealth Advisors's AKRO Position: Q4 2025 in Review

JFS Wealth Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1 share — an estimated $48 sold.

JFS Wealth Advisors first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $48 in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • JFS Wealth Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • JFS Wealth Advisors sold 1 Akero Therapeutics share in Q4 2025, an estimated $48.
  • JFS Wealth Advisors first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • JFS Wealth Advisors's Akero Therapeutics position peaked at $48 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on JFS Wealth Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.